CD4 and myeloid sarcoma: Thus, the studied low-efficacy drugs normalized MS-associated changes in CSF lymphocytes, whereas high-efficacy treatments introduced non-physiological changes with more pronounced decrease in CD4+ T cells as compared to CD8+ T cells and non-physiological decreases in CSF CD4/CD8 ratio.